These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 19764889
1. Motavizumab for the prevention of respiratory syncytial virus infection in infants. Gill MA, Welliver RC. Expert Opin Biol Ther; 2009 Oct; 9(10):1335-45. PubMed ID: 19764889 [Abstract] [Full Text] [Related]
2. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. Wu H, Pfarr DS, Johnson S, Brewah YA, Woods RM, Patel NK, White WI, Young JF, Kiener PA. J Mol Biol; 2007 May 04; 368(3):652-65. PubMed ID: 17362988 [Abstract] [Full Text] [Related]
3. Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations. Weisman LE. Curr Opin Mol Ther; 2009 Apr 04; 11(2):208-18. PubMed ID: 19330726 [Abstract] [Full Text] [Related]
4. New strategies for control of respiratory syncytial virus infection. Nokes JD, Cane PA. Curr Opin Infect Dis; 2008 Dec 04; 21(6):639-43. PubMed ID: 18978532 [Abstract] [Full Text] [Related]
10. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics; 2003 Dec 04; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [Abstract] [Full Text] [Related]
16. Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children. Lagos R, DeVincenzo JP, Muñoz A, Hultquist M, Suzich J, Connor EM, Losonsky GA. Pediatr Infect Dis J; 2009 Sep 01; 28(9):835-7. PubMed ID: 19636278 [Abstract] [Full Text] [Related]
17. Palivizumab in the prophylaxis of respiratory syncytial virus infection. Cardenas S, Auais A, Piedimonte G. Expert Rev Anti Infect Ther; 2005 Oct 01; 3(5):719-26. PubMed ID: 16207163 [Abstract] [Full Text] [Related]
20. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. Cox RA, Rao P, Brandon-Cox C. J Hosp Infect; 2001 Jul 01; 48(3):186-92. PubMed ID: 11439005 [Abstract] [Full Text] [Related] Page: [Next] [New Search]